Daniel Fein

Adult Pulmonary and Critical Care Physician, ICU director

[Daniel Fein @DanielGFein]

@NEJM Interesting practice variation regarding variability of VL type across DEVICE. Should @MontefioreCCM consider use of MAC blade VL, in addition to hyperangulated, for our intubation toolbox, or is inter-facility practice variation dangerous among trainee operators? @ATSCritCare

[Daniel Fein @DanielGFein]

Matt Semler from @PCCRG further breaks down DEVICE results. Intersection between operator experience and choice of intubating device. For operator with <= 25 intubations, NNT only 4 patients to prevent one first attempt failure. @ATSCritCare @MontefioreCCM @MontefiorePulm

[Daniel Fein @DanielGFein]

DEVICE trial showing superior success on first attempt with use of video laryngoscopy.

Superior success was most profound among junior operators. Is it still ethical to teach DL to trainees? Awesome study @PCCRG! @ATSCritCare @MontefiorePulm @MontefioreCCM

[Daniel Fein @DanielGFein]

@direddy Awesome posters. Thanks so much @MontefiorePulm fellows for your hard work on these projects. @EinsteinDeptMed

[Hannah Wunsch @wunschcritcare]

Doesn’t get any better than the great ⁦@CornerBooksNYC⁩ displaying one’s book like this! A packed house and fantastic event celebrating The Autumn Ghost. ⁦@greystonebooks⁩ 🍁👻

[Daniel Fein @DanielGFein]

@wunschcritcare tells us at @EinsteinDeptMed grand rounds that ventilators were first called “mechanical students” because med students were the primary mechanism to bag patients non-stop through respiratory failure. @ATSCritCare @MontefioreCCM

[Daniel Fein @DanielGFein]

@wunschcritcare here at @MontefioreCCM @EinsteinDeptMed grand rounds. Telling us how critical care began.

[Pulm PEEPs @PulmPEEPs]

We’re back from #ATS2023 with a preview of a @ATSCritCare symposium that is happening this afternoon!

Listen to @almoskow tell us the highlights of Cardiac Arrest: New Evidence and Changing Guidelines. From ECPR to temp management to calcium to survivorship

@atscommunity

[Daniel Fein @DanielGFein]

Is it really more difficult to intubate an obese patient? Our data suggests that obesity by itself is not a risk factor for failure of intubation on the first attempt. https://t.co/rFWf73oDkY @ATSCritCare @PCCRG @almoskow @NaukaPeter @arielshiloh

[Daniel Fein @DanielGFein]

@MHayes_MD telling us about 3 wishes project for patients dying in ICU. Potential to provide additional meaning at end of life for patient, family and care team. @ATSCritCare

[Daniel Fein @DanielGFein]

@MHayes_MD tells us the essential components of a human ICU. @ATSCritCare

[Daniel Fein @DanielGFein]

@efan75 ECMO take home points. Early ECMO probably better. ECMO probably more helpful for less critical hypoxemia (p/f>66) as shown in stratified EOLIA data. @ATSCritCare

[Daniel Fein @DanielGFein]

@efan75 tells us that ECMO outcomes for patients with COVID similar to non-COVID patients. Risk factors for poor outcome include a less experienced center. @ATSCritCare

[Daniel Fein @DanielGFein]

@almoskow summarizing the conflicting data for ECPR post arrest. @ATSCritCare @MontefiorePulm @MontefioreCCM

[Daniel Fein @DanielGFein]

@almoskow telling us about dual sequential defibrillation utility for refractory shockable rhythm in cardiac arrest at NY @atscommunity. @MontefioreCCM @ATSCritCare

[Daniel Fein @DanielGFein]

@almoskow @alanarsiev @tchen383 @MichelleNgGong @ValeriaFabreMD @MontefioreID @MontefioreDGIM @montefioreIM @YoramPuiusMD @WendyStead5 @MontefioreCCM @MHayes_MD Awesome work. Everything we do in medicine should be preceded by the question, “will this intervention help my patient?” This question should not change according to how sick a patient is. @ATSCritCare

[Daniel Fein @DanielGFein]

Kathryn Hibbert tells us about the EOLIA rorschach test. A great example of how we all use clinical trial results to reinforce our pre-conceived beliefs. How you felt about ECMO before can be reinforced by the study results. Everyone wins? @ATSCritCare

[Daniel Fein @DanielGFein]

What can peep do for you!?!? Improve lung compliance! Old but cool data. Thanks Kathryn Hibbert. @ATSCritCare @atscommunity

[Daniel Fein @DanielGFein]

Why so many drug trials haven’t panned out for ARDS treatment @kathrynhibbert tells us at NY thoracic. Except steroids of course. @ATSCritCare @atscommunity

[Daniel Fein @DanielGFein]

We have been progressively getting better at intubating on the first attempt. Should we start using a different outcome for figuring out if we are good at airway management? https://t.co/siTVJRSeKt
@almoskow @NaukaPeter @ATSCritCare @AnnalsATS @atscommunity